comparemela.com

Latest Breaking News On - James vane tempest - Page 8 : comparemela.com

SCHOTT PHARMA : Jefferies reaffirms its Neutral rating -November 07, 2023 at 01:10 am EST

In a research note, Jefferies analyst James Vane-Tempest has maintained his recommendation on the stock with a Neutral rating.

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies keeps a Sell rating -November 02, 2023 at 05:50 am EDT

In his latest research note, analyst James Vane-Tempest confirms his negative recommendation. The broker Jefferies is keeping its Sell rating. The target price remains unchanged at EUR 29.

FRESENIUS SE : Receives a Buy rating from Jefferies -November 02, 2023 at 05:54 am EDT

In a research note published by James Vane-Tempest, Jefferies advises its customers to buy the stock. The target price continues to be set at EUR 41.

PHILIPS NV : Jefferies reiterates its Sell rating -October 23, 2023 at 03:44 am EDT

The analyst from Jefferies, James Vane-Tempest, maintains his advice to sell. The target price is still set at EUR 11.40.

GERRESHEIMER AG : Jefferies maintains a Buy rating -October 19, 2023 at 10:03 am EDT

Already positive, the research from Jefferies and its analyst James Vane-Tempest still consider the stock as a Buy opportunity. The target price is lowered from EUR 143 to EUR 130.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.